StockData
COSCIENS Biopharma Inc. logo

COSCIENS Biopharma Inc. (CSCIF) stock

CSCIFOTCPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 20-F on Mar 25, 2026Score 1/30
$6.49+0.00 (0.00%)

Close on Oct 19, 2026Market cap $24.10MP/E –Yield –

Earnings

COSCIENS Biopharma's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q1 FY2026
$1.90M
-42.4% on a year earlier
EPS, Q1 FY2026
$3.42
-$2.15 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of COSCIENS Biopharma's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q1 FY2026ended Mar 31, 2026May 12, 2026during market hours$1.90M-42.4%$3.42Release
Q4 FY2025ended Dec 31, 2025Mar 25, 2026during market hours$1.80M–$0.69Release
Q3 FY2025ended Sep 30, 2025Nov 12, 2025before the open$1.50M-21.1%$0.57Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025during market hours$2.70M+17.4%-$0.75Release
Q1 FY2025ended Mar 31, 2025Apr 9, 2025during market hours$3.30M–-$2.15Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024before the open$1.90M–-$1.85Release
Q2 FY2024ended Jun 30, 2024Aug 13, 2024before the open$2.30M–-$0.64Release
Q1 FY2024ended Mar 31, 2024May 15, 2024during market hours––-$4.74Release
Q3 FY2023ended Sep 30, 2023Nov 9, 2023before the open$0–-$0.85Release
Q2 FY2023ended Jun 30, 2023Aug 9, 2023before the open–––Release
Q1 FY2023ended Mar 31, 2023May 9, 2023during market hours–––Release
Q4 FY2022ended Dec 31, 2022Mar 23, 2023before the open–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

COSCIENS Biopharma has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When COSCIENS Biopharma puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases COSCIENS Biopharma filed with the SEC as exhibits to Form 8-K or 6-K

  1. 6-K
  2. 6-K
  3. 6-K
  4. 6-K
  5. 6-K
  6. 6-K
  7. 6-K
  8. 6-K
  9. 6-K
  10. 6-K
  11. 6-K
  12. 6-K
  13. 6-K
  14. 6-K
  15. 6-K

See a number that looks wrong?